Aytu BioScience is trading 5.88% up at $2.25 as investors position ahead of its fiscal 2026 full-year and fourth-quarter results, scheduled after the market close on September 22, 2026.
- Management will discuss the results during a 4:30 p.m. Eastern conference call.
- No completed earnings figures or separate company announcement were available by 10:22 a.m. Eastern.